Suzhou Neologics Bioscience Co., Ltd.
1 clinical trials · Sponsor
◉ Watch Suzhou Neologics Bioscience Co., Ltd.
| Record | Firm | Date |
|---|---|---|
| A Dose Escalation and Expansion Study of NB002 in Participants With Advanced or Metastatic Solid Tumors (NCT05924906) | Suzhou Neologics Bioscience Co., Ltd. | 2023-10-01 |
Track Suzhou Neologics Bioscience Co., Ltd. automatically
Every clearance here is in the API, with alerts when new ones post.